Stock Analysis
Shandong Fengyuan Chemical Third Quarter 2024 Earnings: CN¥0.17 loss per share (vs CN¥0.16 loss in 3Q 2023)
Shandong Fengyuan Chemical (SZSE:002805) Third Quarter 2024 Results
Key Financial Results
- Revenue: CN¥382.7m (down 56% from 3Q 2023).
- Net loss: CN¥48.7m (loss widened by 13% from 3Q 2023).
- CN¥0.17 loss per share (further deteriorated from CN¥0.16 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Shandong Fengyuan Chemical shares are up 17% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Shandong Fengyuan Chemical has 3 warning signs (and 2 which are a bit unpleasant) we think you should know about.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:002805
Shandong Fengyuan Chemical
Engages in the research and development, production, and sale of industrial oxalic acid, refined oxalic acid, and oxalic acid derivatives in China and internationally.
